Stock screenerAll disclosures →
EDGAR →
RGNX
Conviction 58HealthcareScan · Thu, Jun 25, 2026Shooting star
RGNX$10.21+2.41%
ResistanceSupportVol 14Insider sellVol MA14 2.59M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price10.21
Change+2.41%
Gap+1.00%
Rel volume1.42×
Avg volume2.21M
Avg $ vol17.65M
SMA 207.38
SMA 508.01
SMA 20010.34
Price vs 50+27.41%
Price vs 200-1.28%
MA stackmixed
50/200 cross—
Supertrendup · 7.81
RSI (14)72
MACD hist0.49
MACD cross—
Stoch %K / %D85 / 85
ADX (14)24
+DI / −DI40 / 12
RSI divergence—
MACD divergence—
ATR %+8.03%
ADR %9.00%
52w high15.98
52w low5.65
From 52w high-36.11%
Above 52w low+80.71%
New 52w highNo
SqueezeOff
Bollinger width71.11%
%B1.04
Donchian pos84.90%
Donchian high10.98
Donchian low5.88
AVWAP (52w high)8.46
vs AVWAP high+20.73%
AVWAP (52w low)7.53
vs AVWAP low+35.50%
OBV trendUp
Chaikin MF (20)0.01
Today vs 20d1.42×
Avg vol (14d)2.59M
Avg vol (20d)2.21M
Avg $ vol (20d)17.65M
Market cap527.83M
RS 3m (vs SPY)+15.40%
RS 6m (vs SPY)-39.40%
RS line new highNo
Trend template3/8
Technical rank53.0
1 week+29.24%
1 month+61.81%
3 months+20.69%
6 months-31.80%
1 year+19.28%
YTD-24.76%
P/E-2.72
P/B25.04
P/S3.10
P/FCF-4.18
EPS-3.76
Div yield—
ROE-919.64%
ROA-56.71%
Debt/Eq—
Current2.62
EV/EBITDA-3.52
Gross margin—
Net margin-113.75%
Rev growth104.54%
EPS growth14.63%
Price target20.89
Target upside104.60%
Analyst ratingBuy
Institutional89.53%
Ent. value512.6M
Revenue6.39M
Net income-90.05M
Gross profit—
Free cash flow-126.38M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out51.7M
Employees371
ListedThu, Sep 17, 2015
Free float38.66M
Float %74.9%
Short interest8.28M
Days to cover4.5d
Short volume43.3%
Squeeze score71 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast$0.12 · 5 est
Last EPS vs est−$1.72 vs −$1.36
Last surprise-26.5% miss
Setup gradeC
Conviction58 / 100
Pattern quality—
Tech rank53.0 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RGNX
No recent disclosed trades by Congress in RGNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RGNX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bennett Jean Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Tasse Daniel Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Zachary Jennifer Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Glucksmann Alexandra Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
KARABELAS ARGERIS N Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Glucksmann Alexandra Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Tasse Daniel Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Zachary Jennifer Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Fox Allan M. Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
KARABELAS ARGERIS N Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in RGNX · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.